Bill Ackman Says Pershing Square Has Achieved a 20% Gross Annual Return Since Inception and Aims to Keep Beating That Bar. Can His Newly Launched Funds Live Up to the Track Record?

Pershing Square’s new U.S.-listed closed-end fund (NYSE: PSUS) is down ~21% since its April 29 IPO (priced at $50, trading around $39), while the S&P 500 is up ~7% over the same period. Ackman reiterates a long-term strategy targeting gross returns >20%/yr and expects holdings to grow EPS by at least 15% annually over the next 3–5 years. The firm also plans to launch Pershing Square Ventures to give public investors access to pre-IPO/private high-growth companies, targeting a debut by end-2026 with “substantially” lower fees than typical private venture funds.

Analysis

PSUS looks less like a differentiated alpha vehicle and more like a wrapper around a handful of mega-cap factors with an added fee/structure drag. In the next 1-3 months, the main market mechanism is technical: if the fund keeps trading below implied NAV, that discount can become self-reinforcing because new capital is slower to arrive into a product that investors can replicate more cheaply with ETFs and single names. The upside case is limited unless AUM growth accelerates meaningfully; otherwise the halo effect is mostly branding, not incremental demand power.

For the underlying holdings, any direct price impact is likely marginal because the fund’s assets are too small relative to the float of MSFT, META, AMZN, and UBER to move valuation by themselves. The second-order effect is actually competitive: PSUS may siphon active capital away from higher-fee long-only products that hold the same names, while the listed structure commoditizes “Ackman access” and compresses the scarcity value of his public-equity edge. That is negative for PSUS as an instrument, but neutral-to-slightly positive for the liquid large-cap basket because it creates another buyer of the same crowded winners.

The venture fund is a longer-dated option on private growth exposure, but the debut timing into end-2026 means it is not a near-term catalyst. The contrarian risk is consensus may be overvaluing brand transferability: public-market skill does not automatically translate to pre-IPO pricing discipline, and if the venture arm disappoints, it could become a reputational overhang rather than an asset. What would falsify the bearish wrapper thesis is sustained narrowing of the discount to NAV or a visible step-up in subscriptions over the next two quarters.

Key Decisions for Investors

• Fade PSUS strength over the next 1-3 months: short PSUS on any rally toward closer-to-NAV pricing, with a stop if the discount narrows materially or new AUM traction is disclosed.
• Relative-value pair: long a self-built basket of disclosed core holdings (MSFT/META/AMZN/UBER/QSR) versus short PSUS if borrow/liquidity are workable; thesis is to isolate the fee/structure drag and avoid paying for the wrapper.
• Do not chase the venture-fund narrative yet; treat it as a 2026 watch item. Reassess only if there is evidence of real private-market access, anchor LP demand, or a credible pipeline that can be verified independently.
• Monitor PSUS discount to implied NAV and quarterly net flows as the key falsifiers. If the discount persists or widens through the next two reporting periods, the market is signaling the product is not accumulating durable demand.